From 2013 to 2023, the Penicillins and Streptomycins dosage market in Luxembourg exhibited modest yet fluctuating growth, standing at USD 3.4358 million in 2023. The year-on-year growth showed significant volatility, with notable peaks in 2014 and 2019 due to specific market dynamics, before stabilizing at a CAGR of 2.7% over the last five years. In the more recent years, growth has been relatively subdued.
Future trends to watch for:
- Increased demand due to a rising focus on antibiotic-resistant infections.
- Potential impact of regulatory changes at the EU level on pricing and availability.
- Technological advancements in pharmaceutical manufacturing that could affect production costs.
How does Luxembourg rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 30 | 30 Moldova | 5,776,600 | 2023 | -4.38% | -6.74% | View data |
| 31 | 31 Armenia | 5,084,600 | 2023 | -2.21% | -0.94% | View data |
| 32 | 32 Luxembourg | 3,435,800 | 2023 | +0.84% | +2.7% | |
| 33 | 33 Estonia | 2,300,800 | 2023 | -17.73% | -11.1% | View data |
